BackBiocryst Pharmaceuticals Overview

Biocryst Pharmaceuticals Inventory

Track Biocryst Pharmaceuticals's inventory ($6.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$6.06M
↑ 20.06% YoYΔ $1.01M vs prior year quarter

Peer trimmed avg / median

Loading

Biocryst Pharmaceuticals Inventory History

Loading

Biocryst Pharmaceuticals vs. peers: Inventory Comparison

Loading

Biocryst Pharmaceuticals Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biocryst Pharmaceuticals (BCRX) FAQ

As of the most recent data (June 2026), BCRX shows a inventory of $6.1M. That compares with $5M in the prior-year period — up 20.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCRX's inventory is now $6.1M (was $5M) — a 20.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biocryst Pharmaceuticals is outperforming or lagging.

Tracking BCRX's inventory over time shows whether Biocryst Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $6.1M That compares with $5M in the prior-year period — up 20.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Biocryst Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $6.1M) with ownership activity and broader fundamentals.

Biocryst Pharmaceuticals's inventory is $6.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.